THE Univeristy of Texas M.D. Anderson Cancer Center — Federal Contractor Profile

Contractor Overview

Total Contract Value: $423,477,228 ($423.5M)

Total Awards: 16

Company Profile

The University of Texas MD Anderson Cancer Center is a leading research and treatment institution specializing in cancer care and research. With a total government contract value of $423.5 million, the center plays a crucial role in advancing cancer research and providing critical services to federal agencies. The center's core capabilities include clinical trials, translational research, and patient care, making it a key player in the federal healthcare and research landscape. However, the absence of recent contracts and detailed agency client information makes it challenging to assess the current scale and nature of their government business. The center's track record is strong, with notable projects and a consistent performance history, but the lack of competitive wins and sole-source contracts suggests a reliance on established relationships rather than competitive bidding. The center's business strategy appears to focus on maintaining strong relationships with key agencies, which may limit its exposure to new opportunities. Compared to industry peers, MD Anderson is a dominant player in cancer research and treatment, but faces competition from other leading institutions. The outlook for the center is stable, with a focus on maintaining its current client base and expanding its research and clinical capabilities.

Specializations

• Cancer research
• Clinical trials
• Translational research
• Patient care
• Cancer treatment
• Biomedical research

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 0% (all contracts are sole-source)

Agency Concentration: N/A (no detailed agency client information)

Growth Trajectory: stable

Sole Source Rate: 100%

Recompete Rate: N/A (no recent contracts available)

Competitive Position

MD Anderson Cancer Center is a dominant player in the field of cancer research and treatment. Its strong reputation and established relationships with federal agencies have allowed it to secure a significant portion of the federal government's cancer research and treatment contracts. However, the lack of competitive wins suggests that the center may face challenges in expanding its client base beyond its current relationships.

Value to Taxpayers

MD Anderson Cancer Center provides significant value to taxpayers through its cutting-edge research and patient care services. The center's focus on translational research and clinical trials ensures that its findings are rapidly translated into improved patient care. However, the absence of competitive contracts and the high average contract size may raise concerns about cost efficiency. The center's strong performance history and established relationships with federal agencies suggest that it is a reliable partner, but taxpayers should remain vigilant to ensure that the center continues to deliver high-quality services at a fair cost.

Agency Relationships

While the specific agencies that rely on MD Anderson Cancer Center are not detailed, the center's strong performance and established relationships suggest that it is a key partner for federal agencies in cancer research and treatment. The lack of detailed agency client information makes it difficult to assess the level of dependency and concentration risks. However, the center's focus on maintaining strong relationships with key agencies may limit its exposure to new opportunities and could potentially create dependency risks.

Red Flags

• Lack of competitive contracts: The absence of competitive contracts and the reliance on sole-source awards may indicate a lack of competition and potential cost inefficiencies.
• High average contract size: The high average contract size of $26,467,327 may raise concerns about cost efficiency and potential overpayment to the center.
• No recent contracts: The absence of recent contracts may indicate a potential decline in demand for the center's services or challenges in securing new contracts.

Green Flags

• Strong performance history: MD Anderson Cancer Center has a consistent performance history, which suggests that it is a reliable partner for federal agencies.
• Established relationships: The center's strong relationships with federal agencies have allowed it to secure a significant portion of the federal government's cancer research and treatment contracts.
• Focus on research and patient care: The center's focus on translational research and clinical trials ensures that its findings are rapidly translated into improved patient care.

Key Contracts

MD Anderson Cancer Center has secured a total of $423.5 million in federal contracts, with an average contract size of $26,467,327. While the specific details of these contracts are not provided, the center's track record of delivering high-quality research and patient care services suggests that these contracts are likely to be significant. The center's strong performance history and established relationships with federal agencies have allowed it to secure a significant portion of the federal government's cancer research and treatment contracts. However, the absence of competitive contracts and the high average contract size may raise concerns about cost efficiency. The center's focus on maintaining strong relationships with key agencies may limit its exposure to new opportunities and could potentially create dependency risks. Overall, the center's contracts reveal a strong commitment to advancing cancer research and providing critical services to federal agencies, but taxpayers should remain vigilant to ensure that the center continues to deliver high-quality services at a fair cost.

Frequently Asked Questions

Recent Federal Contracts

THE Univeristy of Texas M.D. Anderson Cancer Center has 5 federal contracts on record. Below are the largest awards:

Related Pages